Crispr Therapeutics Ag (CRSP)

Revenue

$12.67M

Quarterly · Period ending: · USD

CRSP logo

CRSP Revenue

Latest reported$12.67M
CRSP Quarterly Revenue ($0.00 → $12.67M)
High-resolution chart · PNG

CRSP revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Revenue — Quarterly (USD)
Period endingRevenue (USD)
12,669,000
10,181,000
1,458,000
864,000
889,000
892,000
865,000
35,000,000
602,000
517,000
504,000
200,000,000
0
70,000,000
100,000,000
6,000
94,000
158,000
178,000
12,899,000
329,000
900,202,000
202,000
370,000
148,000
44,000
157,000
77,016,000
211,928,000
318,000
328,000
115,000
563,000
1,088,000
1,358,000
32,325,000
2,387,000
3,582,000
2,703,000
2,344,000
1,549,000
795,000
476,000
247,000
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.